Ghent University Academic Bibliography

Global variation in lipoprotein(a) levels among patients with coronary heart disease : insights from the INTERASPIRE study and implications for emerging Lp(a)-lowering therapies

Fotios Barkas, Julia Brandts, Dirk De Bacquer (UGent) , Catriona Jennings, Gui De Backer (UGent) , Kornelia Kotseva, Lars Ryden, Gregory Y.H. Lip, Raul D. Santos, Peter Libby, et al.

(2025) JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 85(21). p.2028-2042

Add to list

Dysglycaemia screening and its prognostic impact in patients with coronary artery disease : experiences from the EUROASPIRE IV and V cohort studies

Giulia Ferrannini, Jaakko Tuomilehto, Gui De Backer (UGent) , Kornelia Kotseva, Linda Mellbin, Oliver Schnell, David Wood, Dirk De Bacquer (UGent) and Lars Rydén

(2024) LANCET DIABETES & ENDOCRINOLOGY. 12(11). p.790-798

Add to list

Variation in secondary prevention of coronary heart disease : the INTERASPIRE study

John William McEvoy, Catriona Jennings, Kornelia Kotseva, Dirk De Bacquer (UGent) , Gui De Backer (UGent) , Iris Erlund, Terhi Vihervaara, Gregory Y H Lip, Kausik K Ray, Lars Rydén, et al.

(2024) EUROPEAN HEART JOURNAL. 45(39). p.4184-4196

Add to list

Miscellaneous

Obituary for Kalevi Pyörälä (1930–2023)

Gui De Backer (UGent)

(2023) EUROPEAN HEART JOURNAL. 44(17). p.1491-1492

Add to list

Journal Article
A1
open access

Diminishing benefits of urban living for children and adolescents’ growth and development

[missing] NCD Risk Factor Collaboration (NCD-RisC), Anu Mishra, Bin Zhou, Andrea Rodriguez-Martinez, Honor Bixby, Rosie K. Singleton, Rodrigo M. Carrillo-Larco, Kate E. Sheffer, Christopher J. Paciorek, James E. Bennett, et al.

(2023) NATURE. 615(7954). p.874-883

Add to list

Journal Article
A1
open access

Treatment goal attainment for secondary prevention in coronary patients with or without diabetes mellitus : Polish multicenter study POLASPIRE

Maciej Haberka, Piotr Jankowski, Dariusz A. Kosior, Małgorzata Szpakowicz, Karolina Szóstak-Janiak, Paweł Kozieł, Agnieszka Krzykwa, Magda Łapińska, Małgorzata Setny, Karol Kamiński, et al.

(2023) ARCHIVES OF MEDICAL SCIENCE. 19(2). p.305-312

Add to list

Journal Article

Gender differences in risk factor management and pharmacological treatment among CHD patients : Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys

Pieter Vynckier (UGent) , Johan De Sutter (UGent) , Michel De Pauw (UGent) , Hans Vandekerckhove (UGent) , Gui De Backer (UGent) , Pieter Vervaet (UGent) , Nancy Deweerdt, Paul Dendale, Alexandre Persu, Arne Janssen, et al.

(2023) ACTA CARDIOLOGICA. 78(5). p.607-613

Add to list

2021 ESC guidelines on cardiovascular disease prevention in clinical practice

Frank L J Visseren, François Mach, Yvo M Smulders, David Carballo, Konstantinos C Koskinas, Maria Bäck, Athanase Benetos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno, et al.

(2022) EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 29(1). p.5-115

Add to list

Assessing the probability of risk factor control in patients with coronary heart disease : results from the ESC-EORP EUROASPIRE V survey

Katharina Selda Moerschel, Dirk De Bacquer (UGent) , Gui De Backer (UGent) , David Wood, Kornelia Kotseva, Jürgen Wellmann and Christof Prugger

(2022) EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 29(10). p.1465-1475

Add to list

SCORE 2 : een nieuw model om het risico op cardiovasculaire ziekten in te schatten

Gui De Backer (UGent) and Dirk De Bacquer (UGent)

(2022) TIJDSCHRIFT VOOR GENEESKUNDE. 78(12). p.986-992

Academic Bibliography

Global variation in lipoprotein(a) levels among patients with coronary heart disease : insights from the INTERASPIRE study and implications for emerging Lp(a)-lowering therapies

Dysglycaemia screening and its prognostic impact in patients with coronary artery disease : experiences from the EUROASPIRE IV and V cohort studies

Variation in secondary prevention of coronary heart disease : the INTERASPIRE study

Obituary for Kalevi Pyörälä (1930–2023)

Diminishing benefits of urban living for children and adolescents’ growth and development

Treatment goal attainment for secondary prevention in coronary patients with or without diabetes mellitus : Polish multicenter study POLASPIRE

Gender differences in risk factor management and pharmacological treatment among CHD patients : Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys

2021 ESC guidelines on cardiovascular disease prevention in clinical practice

Assessing the probability of risk factor control in patients with coronary heart disease : results from the ESC-EORP EUROASPIRE V survey

SCORE 2 : een nieuw model om het risico op cardiovasculaire ziekten in te schatten

Contents

Support

Contact